STOCK TITAN

Butterfly Network Inc - BFLY STOCK NEWS

Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.

Overview

Butterfly Network Inc (symbol: BFLY) stands at the forefront of digital health by revolutionizing medical imaging through its innovative handheld ultrasound technology. Combining expertise in digital health, medical imaging, and handheld ultrasound systems, the company is dedicated to democratizing access to diagnostic imaging. By leveraging semiconductor technology and cloud-connected systems, Butterfly Network delivers solutions that are not only affordable and portable but also integrate intelligently into clinical workflows.

Cutting-Edge Technology

The foundation of Butterfly Network’s revolutionary products lies in its proprietary Ultrasound-on-Chip technology. This state-of-the-art semiconductor approach enables the production of a single handheld probe capable of whole-body imaging. The technology fundamentally transforms how ultrasound is applied in both routine and emergent care by replacing bulky, expensive ultrasound machines with a compact, easy-to-use device. The intelligent integration with a mobile application and cloud-connected software further enriches its usability, providing healthcare professionals with instant access to imaging data and remote guidance when needed.

Innovative Business Model and Market Position

Butterfly Network’s business model is markedly different from traditional medical device companies. The company focuses almost exclusively on product and intellectual property development, backed by a group of successful serial entrepreneurs. This unique approach allows for uninterrupted innovation and rapid iteration of its technology portfolio. Butterfly Network generates revenue primarily through the direct sales of its ultrasound devices and ancillary services such as software updates and educational tools. Its low-cost, high-performance products have redefined market expectations and disrupted the conventional imaging space.

Integration of AI and Cloud Connectivity

One of the hallmarks of Butterfly Network’s strategy is the seamless integration of artificial intelligence (AI) into its products. The incorporation of AI-driven applications, such as the ScanLab™ education tool, dramatically enhances the clinical utility of its devices. This AI-guided educational approach provides users with real-time anatomical labels, step-by-step instructions, and performance feedback. The intelligent software not only helps improve scanning proficiency among healthcare practitioners but also supports independent learning, making Butterfly Network an essential partner in modern medical education and clinical practice.

Transforming Medical Education and Clinical Training

Butterfly Network has played a pivotal role in elevating point-of-care ultrasound (POCUS) training. The company collaborates with leading academic institutions such as Kansas City University to integrate its AI-powered ScanLab™ into medical curricula. This initiative enables medical students to gain hands-on experience that is critical to their development as proficient clinicians. By offering a robust, interactive training platform, Butterfly Network ensures that upcoming healthcare professionals are well-versed in modern imaging techniques before entering residency or clinical practice.

Impact on Patient Care and Clinical Workflows

The combination of affordability, portability, and ease-of-use brings ultrasound imaging directly to the point-of-care. Healthcare providers can now perform real-time, whole-body imaging with devices that fit in their pockets. This capability not only enhances diagnostic speed and accuracy but also increases patient engagement by facilitating timely and precise treatment decisions. Butterfly Network’s solution removes the traditional barriers of cost and accessibility, enabling high-quality imaging in diverse settings ranging from urban hospitals to rural clinics and emergency scenarios.

Competitive Landscape and Industry Differentiation

Within the rapidly evolving digital health market, Butterfly Network distinguishes itself by integrating advanced semiconductor technology with intelligent software. While other companies in the medical imaging space may offer traditional ultrasound systems, Butterfly Network’s single-probe solution is unique in its capacity to deliver full-body imaging through a device that is both highly portable and cost-effective. This distinctive product offering not only serves a broad spectrum of clinical applications, including diagnostics in emergent and non-emergent scenarios, but also caters to veterinary medicine and other niche verticals. The emphasis on continuous product innovation and educational support further solidifies its standing among innovators in the field.

Collaboration and Ecosystem Development

Butterfly Network has cultivated a robust ecosystem that spans multiple disciplines, including computer science, physics, and electrical engineering. By drawing on diverse expertise, the company fosters an environment dedicated to continuous technological advancement and innovation. Its strategic partnerships with academic institutions, healthcare organizations, and industry innovators enhance its ability to refine and adapt its offerings to the evolving needs of the healthcare market. In addition, its educational initiatives and collaborative projects have built a network that not only supports clinical practice but also accelerates the adoption of new imaging technologies across global markets.

Comprehensive Approach to Digital Health

At the intersection of medical imaging and digital health, Butterfly Network is committed to both technological innovation and clinical excellence. Its portfolio merges hardware innovation with intelligent, cloud-enabled solutions, ensuring that every product released under its name delivers tangible benefits to healthcare professionals and patients alike. The company also emphasizes education and training as core components of its mission, ensuring that users are equipped to maximize the potential of its technology.

Commitment to Quality and User-Centric Design

Every aspect of Butterfly Network’s product development is underscored by a commitment to quality and usability. The devices are designed with the end-user in mind, enabling straightforward integration into existing clinical workflows and enhancing diagnostic efficacy without compromising on reliability. This pragmatic focus on user experience is reflected in the simple, intuitive interfaces and comprehensive support systems that accompany each product. Moreover, the continuous feedback loop from clinical educators and frontline practitioners helps refine the technology, ensuring it meets the high demands of modern healthcare environments.

Conclusion

Butterfly Network Inc is redefining the landscape of medical imaging with its innovative, handheld ultrasound solutions. Its integration of sophisticated semiconductor technology, AI-driven educational tools, and cloud-connected software creates a unique value proposition that transforms clinical practice and medical training. Through continuous collaboration with academic and healthcare institutions, the company is not only making high-quality ultrasound accessible but is also paving the way for the future of digital health. Its approach embodies a perfect blend of technological ingenuity and clinical pragmatism, making it a significant and enduring player in the field of medical imaging.

Rhea-AI Summary

Butterfly Network (NYSE: BFLY) has announced its participation in the upcoming virtual BTIG Digital Health Forum on November 25, 2024. The company's leadership will engage in two key presentations: a 9:00 AM ET Fireside Chat featuring CEO Joseph DeVivo and CFO Heather Getz discussing Butterfly's technology and strategy, and a 3:00 PM ET Panel Discussion where CMO Dr. John Martin will explore the impact of tools like Butterfly iQ3 on diagnostic and treatment approaches. One-on-one meetings with executives can be arranged through BTIG representatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.2%
Tags
conferences
-
Rhea-AI Summary

Butterfly Network's iQ3™ handheld ultrasound device has won the Best Medical Technology Award at the 2024 Prix Galien USA Awards, often referred to as the 'Nobel Prize of Life Sciences.' The third-generation device, built on Butterfly's proprietary P4.3 semiconductor platform, represents a significant advancement in ultrasound technology with enhanced AI-powered features and digital image capture capabilities. The company's Ultrasound-on-Chip™ technology aims to make ultrasound imaging more affordable, sustainable, and scalable, leveraging Moore's Law to deliver increasingly powerful and cost-effective imaging tools.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.94%
Tags
none
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld ultrasound technology, has announced its participation in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024, in New York City. CEO Joseph DeVivo and CFO Heather Getz will conduct one-on-one meetings throughout the event. DeVivo will present a business overview at 11:00 am ET. The presentation will be available via webcast on the company's investor website until February 19, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.67%
Tags
conferences
Rhea-AI Summary

Butterfly Network (NYSE: BFLY) reported strong Q3 2024 results with revenue of $20.6 million, up 33% year-over-year. The company reduced its net loss by 38% and net cash used in operations by 50%. Product revenue increased 55% to $13.5 million, while software and services revenue grew 5% to $7.0 million. The company launched iQ3 in Europe and expanded into Indonesia, the Netherlands, and Belgium. Based on strong performance, Butterfly raised its full-year 2024 guidance to $79-81 million in revenue and improved its adjusted EBITDA loss forecast to $42-40 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.04%
Tags
-
Rhea-AI Summary

HeartFocus has launched its AI-powered Education app in partnership with Butterfly Network (NYSE: BFLY), designed to teach healthcare practitioners how to conduct clinical-grade heart scans using Butterfly's handheld ultrasound devices. The app helps users master 10 essential cardiac views through personalized, AI-powered learning pathways.

Compatible with Butterfly iQ3 and iQ+ probes on iOS iPads, the platform features advanced gamification for enhanced engagement. The app will be demonstrated at the ANCC MagPath 2024 conference and is currently available in the US and 22 other countries, with a -time offer of a free six-month license.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
AI
-
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY), a digital health company specializing in portable, semiconductor-based ultrasound technology, has announced its plans to report third quarter 2024 financial results on November 1, 2024, at 8:00 am ET. The company will host a conference call and webcast before market opening, featuring Joseph DeVivo, President, CEO, and Chairman of the Board, along with Heather Getz, EVP and CFO/COO.

The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website. Interested parties can also dial in to listen to the call. A replay of the call will be available until November 15, 2024, through various access methods provided in the announcement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.14%
Tags
conferences earnings
Rhea-AI Summary

Kansas City University (KCU) is pioneering point-of-care ultrasound (POCUS) education by introducing a first-of-its-kind, hands-on POCUS elective in its 2024 curriculum. KCU is the first U.S. medical school to use Butterfly Network's AI-guided ScanLab™ application as the foundation of its POCUS curriculum. The program focuses on student scanning proficiency, ensuring graduates are prepared for residency and clinical settings.

The AI-powered ScanLab™ app provides real-time feedback, anatomical labeling, and grading, enabling students to learn independently. Nearly 300 students have enrolled in KCU's POCUS elective series, using personal Butterfly handheld ultrasound devices. This innovative approach addresses the gap in POCUS training in medical schools, setting a new standard for medical education in the 21st century.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
AI
-
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY) has published a case study highlighting the successful implementation of its point-of-care ultrasound (POCUS) devices and Compass™ workflow software at the University of Rochester Medical Center (URMC). The deployment resulted in a 116% increase in ultrasound charge capture across the health system. URMC has deployed 862 Butterfly devices across 64 departments and plans to scale to 2,500 devices by 2026.

Key achievements include:

  • Nearly 50,000 scanning sessions completed since 2022
  • 74% increase in scanning sessions in 2023
  • 147% rise in studies uploaded from Butterfly devices
  • 1,782% jump in images uploaded from non-Butterfly devices

These results have contributed to earlier diagnoses and improved patient outcomes while reducing emergency visits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.92%
Tags
none
-
Rhea-AI Summary

Butterfly Network (NYSE:BFLY) has been named one of 2024's Fierce 50 honorees by Fierce Life Sciences and Fierce Healthcare. This recognition highlights Butterfly's advancements in medical imaging through its portable, semiconductor-based ultrasound technology. Key achievements include:

1. The successful launch of the next-generation Butterfly iQ3™
2. Establishment of the Butterfly Garden™ program for ultrasound AI innovation
3. Creation of a chip-licensing program for partners to develop technologies Powered by Butterfly™

CEO Joseph DeVivo emphasized the company's mission to democratize medical imaging by improving access, affordability, and sustainability. The Fierce 50 recognition underscores Butterfly's role in driving digital revolution in the ultrasound industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.41%
Tags
none
Rhea-AI Summary

Butterfly Network Inc. (NYSE: BFLY) has launched its third-generation handheld point-of-care ultrasound system, Butterfly iQ3™, in Europe. The device, built on advanced Ultrasound-on-Chip™ technology, offers improved image quality, new 3D imaging capabilities, and a smaller, lighter design. Key features include:

1. Unparalleled image quality with twice the processing power of its predecessor
2. Novel tools: iQ Slice™ and iQ Fan™ for advanced 3D imaging
3. Ergonomic design: 17% smaller probe face, 7% shorter probe, and 2.5x faster charging
4. CE marked and EU MDR certified

The Butterfly iQ3 is now available in 16 European countries, expanding the company's mission to democratize ultrasound technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.89%
Tags
none

FAQ

What is the current stock price of Butterfly Network (BFLY)?

The current stock price of Butterfly Network (BFLY) is $2.52 as of April 15, 2025.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately 613.2M.

What is Butterfly Network's core technology?

Butterfly Network utilizes proprietary Ultrasound-on-Chip technology to deliver handheld, whole-body ultrasound imaging. This semiconductor-based approach enables compact, affordable, and high-performance medical imaging.

How does Butterfly Network generate revenue?

The company primarily generates revenue through the direct sales of its ultrasound devices and complementary services, including software and educational tools that support clinical training and practice.

What makes Butterfly Network's ultrasound technology unique?

Its unique integration of semiconductor technology with cloud-connected, AI-powered software allows a single handheld device to deliver high-quality, full-body imaging that is both accessible and easy to use in various clinical settings.

How is Butterfly Network positioned within the digital health market?

Butterfly Network differentiates itself by focusing solely on product and intellectual property development, leveraging advanced technology and strategic partnerships to revolutionize medical imaging and point-of-care diagnostics.

What role does AI play in Butterfly Network's solutions?

AI is integral to the company’s offerings, enhancing clinical workflows through real-time scanning guidance, anatomical labeling, and performance feedback via tools like the ScanLab™ application, which improves both user proficiency and diagnostic accuracy.

How does Butterfly Network support medical education?

The company collaborates with educational institutions to integrate its handheld ultrasound and AI-driven training tools into medical curricula, enabling students to gain practical, hands-on experience that prepares them for clinical practice.

Who are Butterfly Network's main competitors in the market?

While several companies operate within the medical imaging space, Butterfly Network distinguishes itself by combining advanced semiconductor technology with AI and cloud connectivity, setting it apart from traditional ultrasound providers.

What market segments does Butterfly Network serve?

Butterfly Network serves a broad spectrum of market segments including clinical diagnostics, point-of-care assessments, medical education, and even veterinary applications, ensuring its technology is applicable across diverse healthcare settings.
Butterfly Network Inc

NYSE:BFLY

BFLY Rankings

BFLY Stock Data

613.24M
184.42M
14.88%
29.79%
5.07%
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
BURLINGTON